Key Highlights
-
The pharmaceutical sector is the primary driver of clarithromycin demand, fueled by increased prescriptions and public health initiatives.
-
Retail sales of clarithromycin have surged, reflecting heightened consumer awareness and healthcare access.
-
The antibiotic market has experienced significant growth, with clarithromycin leading due to its efficacy against a variety of bacterial infections.
-
Increased consumer spending on healthcare products has led to stockpiling of clarithromycin, further straining supply chains.
The price of clarithromycin has risen from USD ***,*** per metric ton in July to USD ***,*** per metric ton in September in China. Similarly, in the US, prices increased from USD ***,*** per metric ton to USD ***,*** per metric ton over the same timeframe. That *.** increase reflects robust demand patterns in key end-use markets, most notably pharmaceuticals. Sales to retailers have risen as patients increasingly turn to effective treatments against bacterial disease, while industrial use is...
Leave a Comment
Comments (0)